rs146083915

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001715.3(BLK):​c.177C>G​(p.Asp59Glu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00158 in 1,613,942 control chromosomes in the GnomAD database, including 29 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/25 in silico tools predict a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D59N) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0083 ( 15 hom., cov: 32)
Exomes 𝑓: 0.00088 ( 14 hom. )

Consequence

BLK
NM_001715.3 missense, splice_region

Scores

18
Splicing: ADA: 0.00005470
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.733

Publications

6 publications found
Variant links:
Genes affected
BLK (HGNC:1057): (BLK proto-oncogene, Src family tyrosine kinase) This gene encodes a nonreceptor tyrosine-kinase of the src family of proto-oncogenes that are typically involved in cell proliferation and differentiation. The protein has a role in B-cell receptor signaling and B-cell development. The protein also stimulates insulin synthesis and secretion in response to glucose and enhances the expression of several pancreatic beta-cell transcription factors. [provided by RefSeq, Aug 2010]
BLK Gene-Disease associations (from GenCC):
  • maturity-onset diabetes of the young
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • systemic lupus erythematosus
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet
  • maturity-onset diabetes of the young type 11
    Inheritance: AD, Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
  • monogenic diabetes
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0030113757).
BP6
Variant 8-11548033-C-G is Benign according to our data. Variant chr8-11548033-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 361475.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00833 (1268/152294) while in subpopulation AFR AF = 0.028 (1162/41558). AF 95% confidence interval is 0.0266. There are 15 homozygotes in GnomAd4. There are 610 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1268 AD,Unknown gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BLKNM_001715.3 linkc.177C>G p.Asp59Glu missense_variant, splice_region_variant Exon 4 of 13 ENST00000259089.9 NP_001706.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BLKENST00000259089.9 linkc.177C>G p.Asp59Glu missense_variant, splice_region_variant Exon 4 of 13 1 NM_001715.3 ENSP00000259089.4
BLKENST00000533828.1 linkn.375C>G splice_region_variant, non_coding_transcript_exon_variant Exon 2 of 3 4
BLKENST00000645242.1 linkn.328C>G splice_region_variant, non_coding_transcript_exon_variant Exon 3 of 12
BLKENST00000696154.2 linkn.328C>G splice_region_variant, non_coding_transcript_exon_variant Exon 3 of 12

Frequencies

GnomAD3 genomes
AF:
0.00827
AC:
1259
AN:
152176
Hom.:
15
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0278
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00504
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000176
Gnomad OTH
AF:
0.00718
GnomAD2 exomes
AF:
0.00212
AC:
533
AN:
251456
AF XY:
0.00160
show subpopulations
Gnomad AFR exome
AF:
0.0273
Gnomad AMR exome
AF:
0.00176
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000158
Gnomad OTH exome
AF:
0.00130
GnomAD4 exome
AF:
0.000878
AC:
1284
AN:
1461648
Hom.:
14
Cov.:
31
AF XY:
0.000820
AC XY:
596
AN XY:
727148
show subpopulations
African (AFR)
AF:
0.0278
AC:
932
AN:
33472
American (AMR)
AF:
0.00192
AC:
86
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.0000812
AC:
7
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53414
Middle Eastern (MID)
AF:
0.00400
AC:
23
AN:
5744
European-Non Finnish (NFE)
AF:
0.0000980
AC:
109
AN:
1111824
Other (OTH)
AF:
0.00210
AC:
127
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
64
128
191
255
319
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00833
AC:
1268
AN:
152294
Hom.:
15
Cov.:
32
AF XY:
0.00819
AC XY:
610
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.0280
AC:
1162
AN:
41558
American (AMR)
AF:
0.00503
AC:
77
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000176
AC:
12
AN:
68024
Other (OTH)
AF:
0.00710
AC:
15
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
64
129
193
258
322
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00123
Hom.:
2
Bravo
AF:
0.00935
ESP6500AA
AF:
0.0236
AC:
104
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00257
AC:
312
Asia WGS
AF:
0.00346
AC:
12
AN:
3478
EpiCase
AF:
0.000273
EpiControl
AF:
0.000296

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 10, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Maturity-onset diabetes of the young type 11 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Monogenic diabetes Benign:1
Jan 13, 2017
Personalized Diabetes Medicine Program, University of Maryland School of Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

ACMG Criteria:BP4 (9 predictors), BS1 (3.9% in African in 1000g and 2.7% in ExAC), BS2 (seen in 75 controls and 66 cases in type2diabetesgenetics.org) -

Systemic lupus erythematosus Benign:1
-
Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

BLK gene is associated with Systemic lupus erythematosus, sjogren's syndrome and other systemic inflammatory conditions. However no sufficient evidence is found to ascertain the role of this particular variant rs146083915, yet. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
0.39
DANN
Benign
0.26
DEOGEN2
Benign
0.049
T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.028
N
LIST_S2
Benign
0.26
T
MetaRNN
Benign
0.0030
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.41
N
PhyloP100
-0.73
PrimateAI
Benign
0.37
T
PROVEAN
Benign
0.34
N
REVEL
Benign
0.056
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.21
MutPred
0.29
Gain of ubiquitination at K60 (P = 0.068);
MVP
0.71
MPC
0.021
ClinPred
0.0014
T
GERP RS
0.27
Varity_R
0.038
gMVP
0.10
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000055
dbscSNV1_RF
Benign
0.096
SpliceAI score (max)
0.22
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.22
Position offset: 4

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146083915; hg19: chr8-11405542; COSMIC: COSV106089140; COSMIC: COSV106089140; API